KPV
Tripéptido estudiado para efectos antiinflamatorios y relacionados con el intestino
Product Specifications
Description
All presented information is based on scientific publications which can be found at the end of product description below.
KPV es un tripéptido estudiado en investigación antiinflamatoria y relacionada con el intestino. Está listado como compuesto de investigación y no para consumo humano o tratamiento médico.
Research Use Only: The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.
🇪🇺 EU & UK Shipped • Free over €300 • 2-5 Business Days
Frequently asked questions
- KPV is a tripeptide consisting of Lysine-Proline-Valine (Lys-Pro-Val), corresponding to the C-terminal three residues of α-melanocyte-stimulating hormone (α-MSH). Molecular weight is approximately 342 Da. Each batch is HPLC-verified at ≥99% purity.
- KPV is studied for its anti-inflammatory properties in cell culture and animal models, with effects on NF-κB signaling, mast cell modulation, and intestinal barrier integrity in preclinical contexts. All findings are research-grade — no approved clinical use exists.
- Lyophilised at -20 °C in a sealed, desiccant-protected vial for long-term storage. Once reconstituted, follow your lab's protocols; the small molecular weight makes KPV relatively stable in solution but freeze-thaw cycles still degrade activity over time.
- KPV is used in cell culture models of inflammatory bowel disease, atopic dermatitis, and mast cell biology, plus skin wound-healing studies in rodents. The peptide is often researched alongside related α-MSH derivatives.
- No. KPV is not an approved drug in any major regulatory framework and is supplied for laboratory research only.
